Abiopharma

Results of Operations for the Three Months Ended March 31, 2026 - American Overseas Group Limited Announces Net Income Of $3.3 Million For the Three Months Ended March 31, 2026

Synchrony Announces Executive Leadership Changes to Advance Digital Growth, Customer Experience and AI Momentum

Realty Income Prices €600 Million Euro-Denominated Senior Unsecured Notes Offering

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Vantage Corp Issues Statement Regarding Recent Trading Activity

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Nasdaq to Hold Second Quarter 2026 Investor Conference Call

Ampco-Pittsburgh Corporation Joins US small-cap Russell 2000® Index

BXP to Release Second Quarter 2026 Financial Results on July 28, 2026

TFI International to Release Second Quarter 2026 Results